{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:40:14Z","timestamp":1791895214055,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute liver failure (ALF) is characterized by a\u00a0rapid deterioration of liver function and a\u00a0high mortality without transplantation depending on etiology and onset. Immediate transfer to a\u00a0dedicated intensive care unit (ICU) and evaluation for high-urgency liver transplantation (HU-LTx) is recommended to maximize chances of survival. Data on ALF epidemiology are limited, particularly for Central Europe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included all ALF patients admitted to the ICU of the Department of Gastroenterology and Hepatology at the Vienna General Hospital between 2012 and 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 31\u00a0patients (median age of 44 [interquartile range, IQR 32\u201356] years, 20 [65%] female) were included. The primary causes of ALF were viral infections (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u20098; 26%), autoimmune hepatitis (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u20095; 16%), drug-induced liver injury (DILI;\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u20093; 10%), and Wilson\u2019s disease (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u20094; 13%), while in 8\u00a0patients (26%) no cause was identified. Median length of ICU stay was 12 (IQR 4\u201321) days, with mean sequential organ failure assessment (SOFA) and simplified acute physiology score II (SAPS\u00a0II) scores of 10.55\u202f\u00b1\u20094.56 and 40.97\u202f\u00b1\u200914.84. Overall ICU survival was 61% (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u200919). Non-HU-LTx patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u200918) had an ICU survival of 44%. HU-LTx was performed in 13 patients (42%), with 12 patients (92%) surviving 28\u00a0days. The 6\u2011month overall survival of HU-LTx patients was 85%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The diverse causes of ALF in Central Europe include most commonly viral infections, autoimmune hepatitis, and DILI. HU-LTx was required and performed in almost half of patients and was associated with favorable survival rates, underscoring the importance of ICU management and early transfer to liver transplantation centers in the management of ALF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00508-025-02539-1","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:08:23Z","timestamp":1748261303000},"page":"720-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute liver failure in patients admitted to the intensive care unit\u2014a\u00a0Viennese retrospective single-center analysis"],"prefix":"10.1007","volume":"137","author":[{"given":"Patrick","family":"Haselwanter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seanna","family":"Fairfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Riedl-Wewalka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Friedrich","family":"St\u00e4ttermayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Zauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Schneeweiss-Gleixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"2539_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","volume":"394","author":"RT Stravitz","year":"2019","unstructured":"Stravitz\u00a0RT, Lee\u00a0WM. Acute liver failure. Lancet. 2019;394:869\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(19)31894-X.","journal-title":"Lancet"},{"key":"2539_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","volume":"66","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver, et\u00a0al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J\u00a0Hepatol. 2017;66:1047\u201381. https:\/\/doi.org\/10.1016\/j.jhep.2016.12.003.","journal-title":"J Hepatol"},{"key":"2539_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.gastro.2012.07.011","volume":"143","author":"RT Chung","year":"2012","unstructured":"Chung\u00a0RT, et\u00a0al. Pathogenesis of liver injury in acute liver failure. Gastroenterology. 2012;143:e1\u2013e7. https:\/\/doi.org\/10.1053\/j.gastro.2012.07.011.","journal-title":"Gastroenterology"},{"key":"2539_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/s0168-8278(02)00240-4","volume":"37","author":"R Jalan","year":"2002","unstructured":"Jalan\u00a0R, Pollok\u00a0A, Shah\u00a0SH, Madhavan\u00a0K, Simpson\u00a0KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J\u00a0Hepatol. 2002;37:536\u20138. https:\/\/doi.org\/10.1016\/s0168-8278(02)00240-4.","journal-title":"J Hepatol"},{"key":"2539_CR5","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1056\/NEJMra1208937","volume":"369","author":"W Bernal","year":"2013","unstructured":"Bernal\u00a0W, Wendon\u00a0J. Acute liver failure. N\u00a0Engl J Med. 2013;369:2525\u201334. https:\/\/doi.org\/10.1056\/NEJMra1208937.","journal-title":"N Engl J Med"},{"key":"2539_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.clinre.2019.01.005","volume":"43","author":"A Chauhan","year":"2019","unstructured":"Chauhan\u00a0A, Webb\u00a0G, Ferguson\u00a0J. Clinical presentations of Hepatitis\u00a0E: a\u00a0clinical review with representative case histories. Clin Res Hepatol Gastroenterol. 2019;43:649\u201357. https:\/\/doi.org\/10.1016\/j.clinre.2019.01.005.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2539_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jhep.2013.02.010","volume":"59","author":"W Bernal","year":"2013","unstructured":"Bernal\u00a0W, et\u00a0al. Lessons from look-back in acute liver failure? A\u00a0single centre experience of 3300 patients. J\u00a0Hepatol. 2013;59:74\u201380. https:\/\/doi.org\/10.1016\/j.jhep.2013.02.010.","journal-title":"J Hepatol"},{"key":"2539_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.7326\/M15-2211","volume":"164","author":"A Reuben","year":"2016","unstructured":"Reuben\u00a0A, et\u00a0al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med. 2016;164:724\u201332. https:\/\/doi.org\/10.7326\/M15-2211.","journal-title":"Ann Intern Med"},{"key":"2539_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.cgh.2012.02.016","volume":"10","author":"J Hadem","year":"2012","unstructured":"Hadem\u00a0J, et\u00a0al. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol. 2012;10:664\u2013669e2. https:\/\/doi.org\/10.1016\/j.cgh.2012.02.016.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2539_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0140-6736(93)91818-7","volume":"342","author":"JG O\u2019Grady","year":"1993","unstructured":"O\u2019Grady\u00a0JG, Schalm\u00a0SW, Williams\u00a0R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273\u20135. https:\/\/doi.org\/10.1016\/0140-6736(93)91818-7.","journal-title":"Lancet"},{"key":"2539_CR11","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical, A","year":"2013","unstructured":"World Medical, A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"},{"key":"2539_CR12","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.270.24.2957","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall\u00a0JR, Lemeshow\u00a0S, Saulnier\u00a0F. A\u00a0new Simplified Acute Physiology Score (SAPS II) based on a\u00a0European\/North American multicenter study. JAMA. 1993;270:2957\u201363. https:\/\/doi.org\/10.1001\/jama.270.24.2957.","journal-title":"JAMA"},{"key":"2539_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent\u00a0JL, et\u00a0al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707\u201310. https:\/\/doi.org\/10.1007\/BF01709751.","journal-title":"Intensive Care Med"},{"key":"2539_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","volume":"77","author":"European Association for the Study of the, L","year":"2022","unstructured":"European Association for the Study of the, L. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J\u00a0Hepatol. 2022;77:807\u201324. https:\/\/doi.org\/10.1016\/j.jhep.2022.06.001.","journal-title":"J Hepatol"},{"key":"2539_CR15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/lt.21119","volume":"13","author":"A Escorsell","year":"2007","unstructured":"Escorsell\u00a0A, Mas\u00a0A, de la Mata\u00a0M. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl. 2007;13:1389\u201395. https:\/\/doi.org\/10.1002\/lt.21119. Spanish Group for the Study of Acute Liver, F.","journal-title":"Liver Transpl"},{"key":"2539_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1053\/jlts.2002.35556","volume":"8","author":"B Brandsaeter","year":"2002","unstructured":"Brandsaeter\u00a0B, et\u00a0al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation\u201412\u00a0years experience in the nordic countries. Liver Transpl. 2002;8:1055\u201362. https:\/\/doi.org\/10.1053\/jlts.2002.35556.","journal-title":"Liver Transpl"},{"key":"2539_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jhep.2008.09.012","volume":"50","author":"W Bernal","year":"2009","unstructured":"Bernal\u00a0W, et\u00a0al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a\u00a0single centre experience. J\u00a0Hepatol. 2009;50:306\u201313. https:\/\/doi.org\/10.1016\/j.jhep.2008.09.012.","journal-title":"J Hepatol"},{"key":"2539_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/lt.24092","volume":"21","author":"P Ichai","year":"2015","unstructured":"Ichai\u00a0P, et\u00a0al. Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl. 2015;21:512\u201323. https:\/\/doi.org\/10.1002\/lt.24092.","journal-title":"Liver Transpl"},{"key":"2539_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3238\/arztebl.2020.0043","volume":"117","author":"N Weiler","year":"2020","unstructured":"Weiler\u00a0N, Schlotmann\u00a0A, Schnitzbauer\u00a0AA, Zeuzem\u00a0S, Welker\u00a0MW. The epidemiology of acute liver failure. Dtsch \u00c4rztebl Int. 2020;117:43\u201350. https:\/\/doi.org\/10.3238\/arztebl.2020.0043.","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"2539_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2012.03.017","volume":"57","author":"G Germani","year":"2012","unstructured":"Germani\u00a0G, et\u00a0al. Liver transplantation for acute liver failure in Europe: outcomes over 20\u00a0years from the ELTR database. J\u00a0Hepatol. 2012;57:288\u201396. https:\/\/doi.org\/10.1016\/j.jhep.2012.03.017.","journal-title":"J Hepatol"},{"key":"2539_CR21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jhep.2024.07.032","volume":"81","author":"European Association for the Study of the Liver","year":"2024","unstructured":"European Association for the Study of the Liver, et\u00a0al. EASL Clinical Practice Guidelines on liver transplantation. J\u00a0Hepatol. 2024;81:1040\u201386. https:\/\/doi.org\/10.1016\/j.jhep.2024.07.032.","journal-title":"J Hepatol"},{"key":"2539_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/lt.26563","volume":"29","author":"CJ Karvellas","year":"2023","unstructured":"Karvellas\u00a0CJ, et\u00a0al. Outcomes of patients with acute liver failure listed for liver transplantation: a\u00a0multicenter prospective cohort analysis. Liver Transpl. 2023;29:318\u201330. https:\/\/doi.org\/10.1002\/lt.26563.","journal-title":"Liver Transpl"},{"key":"2539_CR23","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/hep.26972","volume":"59","author":"P Martin","year":"2014","unstructured":"Martin\u00a0P, DiMartini\u00a0A, Feng\u00a0S, Brown\u00a0R Jr., Fallon\u00a0M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144\u201365. https:\/\/doi.org\/10.1002\/hep.26972.","journal-title":"Hepatology"},{"key":"2539_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","volume":"64","author":"FS Larsen","year":"2016","unstructured":"Larsen\u00a0FS, et\u00a0al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J\u00a0Hepatol. 2016;64:69\u201378. https:\/\/doi.org\/10.1016\/j.jhep.2015.08.018.","journal-title":"J Hepatol"},{"key":"2539_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.09.034","author":"L Burke","year":"2024","unstructured":"Burke\u00a0L, et\u00a0al. Plasma exchange does not improve overall survival in patients with acute liver failure in a\u00a0real-world cohort. J\u00a0Hepatol. 2024; https:\/\/doi.org\/10.1016\/j.jhep.2024.09.034.","journal-title":"J Hepatol"},{"key":"2539_CR26","doi-asserted-by":"publisher","first-page":"11309","DOI":"10.1038\/s41598-024-61658-3","volume":"14","author":"P Haselwanter","year":"2024","unstructured":"Haselwanter\u00a0P, et\u00a0al. Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure. Sci Rep. 2024;14:11309. https:\/\/doi.org\/10.1038\/s41598-024-61658-3.","journal-title":"Sci Rep"},{"key":"2539_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062258","author":"M Popescu","year":"2023","unstructured":"Popescu\u00a0M, et\u00a0al. Artificial liver support with CytoSorb and MARS in liver failure: a\u00a0retrospective propensity matched analysis. J\u00a0Clin Med. 2023; https:\/\/doi.org\/10.3390\/jcm12062258.","journal-title":"J Clin Med"},{"key":"2539_CR28","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1177\/0391398820981383","volume":"44","author":"D Tomescu","year":"2021","unstructured":"Tomescu\u00a0D, Popescu\u00a0M, David\u00a0C, Sima\u00a0R, Dima\u00a0S. Haemoadsorption by CytoSorb(R) in patients with acute liver failure: a\u00a0case series. Int J Artif Organs. 2021;44:560\u20134. https:\/\/doi.org\/10.1177\/0391398820981383.","journal-title":"Int J Artif Organs"},{"key":"2539_CR29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cgh.2015.09.029","volume":"14","author":"RT Stravitz","year":"2016","unstructured":"Stravitz\u00a0RT, et\u00a0al. Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure. Clin Gastroenterol Hepatol. 2016;14:613\u2013620.e4. https:\/\/doi.org\/10.1016\/j.cgh.2015.09.029.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2539_CR30","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/HEP.0000000000000458","volume":"78","author":"RT Stravitz","year":"2023","unstructured":"Stravitz\u00a0RT, et\u00a0al. Future directions in acute liver failure. Hepatology. 2023;78:1266\u201389. https:\/\/doi.org\/10.1097\/HEP.0000000000000458.","journal-title":"Hepatology"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-025-02539-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:23:01Z","timestamp":1762417381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-025-02539-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":30,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2539"],"URL":"https:\/\/doi.org\/10.1007\/s00508-025-02539-1","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.\u00a0Reiberger received grant support from Abbvie, Boehringer Ingelheim, Gilead, Intercept\/Advanz Pharma, MSD, Myr Pharmaceuticals, Philips Healthcare, Pliant, Siemens and W. L. Gore & Associates; speaking\/writing honoraria from Abbvie, Echosens, Gilead, GSK, Intercept\/Advanz Pharma, Pfizer, Roche, MSD, Siemens, W. L. Gore & Associates; consulting\/advisory board fee from Abbvie, Astra Zeneca, Bayer, Boehringer Ingelheim, Gilead, Intercept\/Advanz Pharma, MSD, Resolution Therapeutics, Siemens; and travel support from Abbvie, Boehringer Ingelheim, Dr. Falk Pharma, Gilead, and Roche. M.\u00a0Trauner received grant support from Albireo, Alnylam, Cymabay, Falk, Genentech, Gilead, Intercept, MSD, Takeda and UltraGenyx, honoraria for consulting from AbbVie, Albireo, Agomab, Boehringer Ingelheim, BiomX, Chemomab, Dexoligo Therapeutics, Falk, Genfit, Gilead, GSK, Hightide, Intercept, Ipsen, Jannsen, MSD, Novartis, Phenex, Pliant, Regulus, Siemens and Shire, speaker fees from Albireo, Boehringer Ingelheim, Bristol-Myers Squibb, Falk, Gilead, Ipsen, Intercept, MSD and Madrigal, as well as travel support from AbbVie, Falk, Gilead, Jannsen and Intercept. He is also co-inventor of patents on the medical use of 24-norursodeoxycholic acid filed by the Medical University of Graz. P.\u00a0Haselwanter, S.\u00a0Fairfield, M.\u00a0Riedl-Wewalka, M.\u00a0Schmid, A.\u00a0F. St\u00e4ttermayer, C.\u00a0Zauner and M.\u00a0Schneeweiss-Gleixner declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. It was approved by the local Ethics Committee of the Medical University of Vienna with the Ethics committee number: 1229\/2024. Moreover, the responsible ethics committee waived the informed consent requirement, due to the retrospective setting of the study design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}